Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 722

1.

Prevalence and correlates of hazardous alcohol consumption and binge drinking among men who have sex with men (MSM) in San Francisco.

Santos GM, Rowe C, Hern J, Walker JE, Ali A, Ornelaz M, Prescott M, Coffin P, McFarland W, Raymond HF.

PLoS One. 2018 Aug 17;13(8):e0202170. doi: 10.1371/journal.pone.0202170. eCollection 2018.

PMID:
30118495
2.

Using social media for patient-reported outcomes: A study of genital appearance and sexual function in adult bladder exstrophy patients.

Rowe CK, Shnorhavorian M, Block P, Ahn J, Merguerian PA.

J Pediatr Urol. 2018 Jul 9. pii: S1477-5131(18)30338-3. doi: 10.1016/j.jpurol.2018.05.029. [Epub ahead of print]

PMID:
30078549
3.

Congenital Syphilis: A Discussion of Epidemiology, Diagnosis, Management, and Nurses' Role in Early Identification and Treatment.

Rowe CR, Newberry DM, Jnah AJ.

Adv Neonatal Care. 2018 Jul 16. doi: 10.1097/ANC.0000000000000534. [Epub ahead of print]

PMID:
30020089
4.

Estimates of age-related memory decline are inflated by unrecognized Alzheimer's disease.

Harrington KD, Schembri A, Lim YY, Dang C, Ames D, Hassenstab J, Laws SM, Rainey-Smith S, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Masters CL, Maruff P; AIBL Research Group.

Neurobiol Aging. 2018 Jun 11;70:170-179. doi: 10.1016/j.neurobiolaging.2018.06.005. [Epub ahead of print]

PMID:
30015036
5.

Testing the feasibility of the startle-first route to deimatism.

Holmes GG, Delferrière E, Rowe C, Troscianko J, Skelhorn J.

Sci Rep. 2018 Jul 16;8(1):10737. doi: 10.1038/s41598-018-28565-w.

6.

Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale.

Navitsky M, Joshi AD, Kennedy I, Klunk WE, Rowe CC, Wong DF, Pontecorvo MJ, Mintun MA, Devous MD Sr.

Alzheimers Dement. 2018 Jul 10. pii: S1552-5260(18)31525-5. doi: 10.1016/j.jalz.2018.06.1353. [Epub ahead of print]

PMID:
30006100
7.

Under representation of people with epilepsy and intellectual disability in research.

Shankar R, Rowe C, Van Hoorn A, Henley W, Laugharne R, Cox D, Pande R, Roy A, Sander JW.

PLoS One. 2018 Jun 21;13(6):e0198261. doi: 10.1371/journal.pone.0198261. eCollection 2018.

8.

Author Correction: Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.

Villemagne VL, Doré V, Burnham SC, Masters CL, Rowe CC.

Nat Rev Neurol. 2018 Jun 7. doi: 10.1038/s41582-018-0021-z. [Epub ahead of print]

PMID:
29880829
9.

Potential interference in the Abbott Architect 2nd generation total testosterone assay.

Rowe C, Rabet S.

Ann Clin Biochem. 2018 Jan 1:4563218780888. doi: 10.1177/0004563218780888. [Epub ahead of print] No abstract available.

PMID:
29874926
10.

Multidimensional Family Therapy as a community-based alternative to residential treatment for adolescents with substance use and co-occurring mental health disorders.

Liddle HA, Dakof GA, Rowe CL, Henderson C, Greenbaum P, Wang W, Alberga L.

J Subst Abuse Treat. 2018 Jul;90:47-56. doi: 10.1016/j.jsat.2018.04.011. Epub 2018 Apr 27.

PMID:
29866383
11.

Quantity fluctuations of illicitly used opioids and overdose risk.

Rowe C, Wheeler E, Vittinghoff E, Santos GM, Behar E, Coffin PO.

Int J Drug Policy. 2018 Aug;58:64-70. doi: 10.1016/j.drugpo.2018.05.004. Epub 2018 May 26.

PMID:
29807248
12.

Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.

Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ, Doré V, Dobson A, Masters CL, Waller M, Rowe CC, Maruff P, Donohue MC, Rentz DM, Kirn D, Hedden T, Chhatwal J, Schultz AP, Johnson KA, Villemagne VL, Sperling RA; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging, Biomarker and Lifestyle study of ageing; Harvard Aging Brain Study.

Alzheimers Dement. 2018 May 24. pii: S1552-5260(18)30132-8. doi: 10.1016/j.jalz.2018.04.010. [Epub ahead of print]

PMID:
29803541
13.

The neurotrophic tyrosine kinase receptor TrkA and its ligand NGF are increased in squamous cell carcinomas of the lung.

Gao F, Griffin N, Faulkner S, Rowe CW, Williams L, Roselli S, Thorne RF, Ferdoushi A, Jobling P, Walker MM, Hondermarck H.

Sci Rep. 2018 May 25;8(1):8135. doi: 10.1038/s41598-018-26408-2.

14.

Trajectories of irregular word reading ability as a proxy for premorbid intelligence in Alzheimer's disease, mild cognitive impairment, and healthy aging: A longitudinal study.

Weinborn M, Bucks RS, Sohrabi HR, Rainey-Smith SR, Brown BM, Gardener SL, Gozt A, Christensen D, Savage G, Laws SM, Taddei K, Maruff P, Robertson JS, Ellis KA, Ames D, Masters CL, Rowe CC, Martins RN.

Psychol Assess. 2018 May 21. doi: 10.1037/pas0000565. [Epub ahead of print]

PMID:
29781669
15.

Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography.

Brown BM, Rainey-Smith SR, Dore V, Peiffer JJ, Burnham SC, Laws SM, Taddei K, Ames D, Masters CL, Rowe CC, Martins RN, Villemagne VL.

J Alzheimers Dis. 2018;63(4):1299-1305. doi: 10.3233/JAD-170998.

PMID:
29758940
16.

Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015.

Rowe C, Wheeler E, Stephen Jones T, Yeh C, Coffin PO.

J Urban Health. 2018 May 3. doi: 10.1007/s11524-018-0250-x. [Epub ahead of print]

PMID:
29725887
17.

Reply: Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease?

Mito R, Raffelt D, Dhollander T, Vaughan DN, Tournier JD, Salvado O, Brodtmann A, Rowe CC, Villemagne VL, Connelly A.

Brain. 2018 Jun 1;141(6):e45. doi: 10.1093/brain/awy086. No abstract available.

PMID:
29668851
18.

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R; Contributors.

Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018. Review.

20.

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleo A, Molinuevo JL, Jagust WJ, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, Kornhuber J, Wallin A, Klimkowicz-Mrowiec A, Kandimalla R, Popp J, Aalten PP, Aarsland D, Alcolea D, Almdahl IS, Baldeiras I, van Buchem MA, Cavedo E, Chen K, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gill KD, Gkatzima O, Grimmer T, Hampel H, Herukka SK, Johannsen P, van Laere K, de Leon MJ, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Mroczko B, Nordlund A, Prabhakar S, Peters O, Rami L, Rodríguez-Rodríguez E, Roe CM, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Verhey FRJ, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Vandenberghe R, Brooks DJ, Fladby T, Rowe CC, Drzezga A, Verbeek MM, Sarazin M, Wolk DA, Fleisher AS, Klunk WE, Na DL, Sánchez-Juan P, Lee DY, Nordberg A, Tsolaki M, Camus V, Rinne JO, Fagan AM, Zetterberg H, Blennow K, Rabinovici GD, Hansson O, van Berckel BNM, van der Flier WM, Scheltens P, Visser PJ, Ossenkoppele R.

Alzheimers Dement. 2018 Jul;14(7):913-924. doi: 10.1016/j.jalz.2018.02.009. Epub 2018 Mar 28.

PMID:
29601787
21.

Aged garlic extract supplementation modifies inflammation and immunity of adults with obesity: A randomized, double-blind, placebo-controlled clinical trial.

Xu C, Mathews AE, Rodrigues C, Eudy BJ, Rowe CA, O'Donoughue A, Percival SS.

Clin Nutr ESPEN. 2018 Apr;24:148-155. doi: 10.1016/j.clnesp.2017.11.010. Epub 2018 Jan 3.

22.

Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.

Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, Gupta S, O'Bryant S, Rembach A, Ames D, Ellis K, Fuller SJ, Brown B, Gardener SL, Fernando B, Bharadwaj P, Burnham S, Laws SM, Barron AM, Goozee K, Wahjoepramono EJ, Asih PR, Doecke JD, Salvado O, Bush AI, Rowe CC, Gandy SE, Masters CL.

J Alzheimers Dis. 2018;62(3):965-992. doi: 10.3233/JAD-171145.

23.

Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.

Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D.

Alzheimer Dis Assoc Disord. 2018 Mar 20. doi: 10.1097/WAD.0000000000000252. [Epub ahead of print]

PMID:
29561277
24.

Cross-sectional cause of death comparisons for stimulant and opioid mortality in San Francisco, 2005-2015.

Turner C, Chandrakumar D, Rowe C, Santos GM, Riley ED, Coffin PO.

Drug Alcohol Depend. 2018 Apr 1;185:305-312. doi: 10.1016/j.drugalcdep.2017.12.030. Epub 2018 Feb 21.

PMID:
29486419
25.

Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden.

Rainey-Smith SR, Mazzucchelli GN, Villemagne VL, Brown BM, Porter T, Weinborn M, Bucks RS, Milicic L, Sohrabi HR, Taddei K, Ames D, Maruff P, Masters CL, Rowe CC, Salvado O, Martins RN, Laws SM; AIBL Research Group.

Transl Psychiatry. 2018 Feb 26;8(1):47. doi: 10.1038/s41398-018-0094-x. Review.

26.

Correlates of Validity of Self-Reported Methamphetamine Use among a Sample of Dependent Adults.

Rowe C, Vittinghoff E, Colfax G, Coffin PO, Santos GM.

Subst Use Misuse. 2018 Aug 24;53(10):1742-1755. doi: 10.1080/10826084.2018.1432649. Epub 2018 Feb 20.

PMID:
29461134
27.

Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.

Villemagne VL, Doré V, Burnham SC, Masters CL, Rowe CC.

Nat Rev Neurol. 2018 Apr;14(4):225-236. doi: 10.1038/nrneurol.2018.9. Epub 2018 Feb 16. Review. Erratum in: Nat Rev Neurol. 2018 Jun 7;:.

PMID:
29449700
28.

High performance plasma amyloid-β biomarkers for Alzheimer's disease.

Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, Iwamoto S, Ito K, Tanaka K, Masters CL, Yanagisawa K.

Nature. 2018 Feb 8;554(7691):249-254. doi: 10.1038/nature25456. Epub 2018 Jan 31.

PMID:
29420472
29.

Handling method alters the hedonic value of reward in laboratory mice.

Clarkson JM, Dwyer DM, Flecknell PA, Leach MC, Rowe C.

Sci Rep. 2018 Feb 5;8(1):2448. doi: 10.1038/s41598-018-20716-3.

30.

Ultrasound-mediated cavitation does not decrease the activity of small molecule, antibody or viral-based medicines.

Myers R, Grundy M, Rowe C, Coviello CM, Bau L, Erbs P, Foloppe J, Balloul JM, Story C, Coussios CC, Carlisle R.

Int J Nanomedicine. 2018 Jan 10;13:337-349. doi: 10.2147/IJN.S141557. eCollection 2018.

31.

KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden.

Porter T, Burnham SC, Doré V, Savage G, Bourgeat P, Begemann K, Milicic L, Ames D, Bush AI, Maruff P, Masters CL, Rowe CC, Rainey-Smith S, Martins RN, Groth D, Verdile G, Villemagne VL, Laws SM.

Sci Rep. 2018 Feb 1;8(1):2034. doi: 10.1038/s41598-018-20513-y.

32.

Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β.

Fernando WMADB, Rainey-Smith SR, Gardener SL, Villemagne VL, Burnham SC, Macaulay SL, Brown BM, Gupta VB, Sohrabi HR, Weinborn M, Taddei K, Laws SM, Goozee K, Ames D, Fowler C, Maruff P, Masters CL, Salvado O, Rowe CC, Martins RN; AIBL Research Group.

J Alzheimers Dis. 2018;61(4):1589-1598. doi: 10.3233/JAD-170742.

PMID:
29376865
33.

Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.

Lim YY, Kalinowski P, Pietrzak RH, Laws SM, Burnham SC, Ames D, Villemagne VL, Fowler CJ, Rainey-Smith SR, Martins RN, Rowe CC, Masters CL, Maruff PT.

JAMA Neurol. 2018 Apr 1;75(4):488-494. doi: 10.1001/jamaneurol.2017.4325.

PMID:
29356823
34.

Using medical examiner case narratives to improve opioid overdose surveillance.

Hurstak E, Rowe C, Turner C, Behar E, Cabugao R, Lemos NP, Burke C, Coffin P.

Int J Drug Policy. 2018 Apr;54:35-42. doi: 10.1016/j.drugpo.2017.12.017. Epub 2018 Jan 30.

PMID:
29353022
35.

Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study.

Bell CC, Dankers ACA, Lauschke VM, Sison-Young R, Jenkins R, Rowe C, Goldring CE, Park K, Regan SL, Walker T, Schofield C, Baze A, Foster AJ, Williams DP, van de Ven AWM, Jacobs F, Houdt JV, Lähteenmäki T, Snoeys J, Juhila S, Richert L, Ingelman-Sundberg M.

Toxicol Sci. 2018 Apr 1;162(2):655-666. doi: 10.1093/toxsci/kfx289.

36.

Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease.

Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, Schembri A, Rainey-Smith S, Salvado O, Laws SM, Martins RN, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL research group.

J Affect Disord. 2018 Mar 15;229:269-274. doi: 10.1016/j.jad.2017.12.101. Epub 2018 Jan 3.

PMID:
29329059
37.

Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.

Mito R, Raffelt D, Dhollander T, Vaughan DN, Tournier JD, Salvado O, Brodtmann A, Rowe CC, Villemagne VL, Connelly A.

Brain. 2018 Jan 4. doi: 10.1093/brain/awx355. [Epub ahead of print]

PMID:
29309541
38.

Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity.

Scaria PV, Chen B, Rowe CG, Jones DS, Barnafo E, Fischer ER, Anderson C, MacDonald NJ, Lambert L, Rausch KM, Narum DL, Duffy PE.

PLoS One. 2017 Dec 27;12(12):e0190312. doi: 10.1371/journal.pone.0190312. eCollection 2017.

39.

A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study.

Villemagne VL, Rowe CC, Barnham KJ, Cherny R, Woodward M, Bozinosvski S, Salvado O, Bourgeat P, Perez K, Fowler C, Rembach A, Maruff P, Ritchie C, Tanzi R, Masters CL.

Alzheimers Dement (N Y). 2017 Nov 9;3(4):622-635. doi: 10.1016/j.trci.2017.10.001. eCollection 2017 Nov.

40.

Implementation of a "real world" School-Based Asthma Therapy program targeting urban children with poorly controlled asthma.

Allen ED, Arcoleo K, Rowe C, Long WW.

J Asthma. 2017 Nov 30:1-9. doi: 10.1080/02770903.2017.1396472. [Epub ahead of print]

PMID:
29190172
41.

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.

Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chételat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonça A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Johannsen P, Klimkowicz-Mrowiec A, Köhler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers IHGB, Rami L, Rodríguez-Rodríguez E, Roe CM, Rot U, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Zetterberg H.

JAMA Psychiatry. 2018 Jan 1;75(1):84-95. doi: 10.1001/jamapsychiatry.2017.3391.

PMID:
29188296
42.

Low-threshold extended-release naltrexone for high utilizers of public services with severe alcohol use disorder: A pilot study.

Smith-Bernardin S, Rowe C, Behar E, Geier M, Washington S, Santos GM, Euren J, Martin J, Gleghorn A, Coffin PO.

J Subst Abuse Treat. 2018 Feb;85:109-115. doi: 10.1016/j.jsat.2017.11.005. Epub 2017 Nov 8.

PMID:
29150316
43.

The acute thermal respiratory response is unique among species in a guild of larval anuran amphibians-Implications for energy economy in a warmer future.

Rowe CL, Crandall EA.

Sci Total Environ. 2018 Mar 15;618:229-235. doi: 10.1016/j.scitotenv.2017.10.332. Epub 2017 Nov 9.

PMID:
29128771
44.

A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort.

Pedrini S, Gupta VB, Hone E, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN; AIBL Research Group.

Sci Rep. 2017 Oct 25;7(1):14057. doi: 10.1038/s41598-017-14020-9.

45.

Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial.

Coffin PO, Santos GM, Matheson T, Behar E, Rowe C, Rubin T, Silvis J, Vittinghoff E.

PLoS One. 2017 Oct 19;12(10):e0183354. doi: 10.1371/journal.pone.0183354. eCollection 2017.

46.

Neurotrophin Receptors TrkA, p75NTR, and Sortilin Are Increased and Targetable in Thyroid Cancer.

Faulkner S, Jobling P, Rowe CW, Rodrigues Oliveira SM, Roselli S, Thorne RF, Oldmeadow C, Attia J, Jiang CC, Zhang XD, Walker MM, Hondermarck H.

Am J Pathol. 2018 Jan;188(1):229-241. doi: 10.1016/j.ajpath.2017.09.008. Epub 2017 Oct 14.

PMID:
29037860
47.

Measuring the impact of teaching approaches on achievement-related emotions: The use of the Achievement Emotions Questionnaire.

Starkey-Perret R, Deledalle A, Jeoffrion C, Rowe C.

Br J Educ Psychol. 2017 Sep 25. doi: 10.1111/bjep.12193. [Epub ahead of print]

PMID:
28944463
48.

Perfused human hepatocyte microtissues identify reactive metabolite-forming and mitochondria-perturbing hepatotoxins.

Rowe C, Shaeri M, Large E, Cornforth T, Robinson A, Kostrzewski T, Sison-Young R, Goldring C, Park K, Hughes D.

Toxicol In Vitro. 2018 Feb;46:29-38. doi: 10.1016/j.tiv.2017.09.012. Epub 2017 Sep 15.

PMID:
28919358
49.

Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline.

Ayton S, Fazlollahi A, Bourgeat P, Raniga P, Ng A, Lim YY, Diouf I, Farquharson S, Fripp J, Ames D, Doecke J, Desmond P, Ordidge R, Masters CL, Rowe CC, Maruff P, Villemagne VL; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group, Salvado O, Bush AI.

Brain. 2017 Aug 1;140(8):2112-2119. doi: 10.1093/brain/awx137.

PMID:
28899019
50.

Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry.

Frost S, Robinson L, Rowe CC, Ames D, Masters CL, Taddei K, Rainey-Smith SR, Martins RN, Kanagasingam Y.

J Ophthalmol. 2017;2017:7935406. doi: 10.1155/2017/7935406. Epub 2017 Aug 16.

Supplemental Content

Support Center